Life science researchers’ interests and needs grow around understanding the mechanism of disease and toxicity. Agilent Technologies provides an integrated, multidisciplinary approach utilizing genomics, transcriptomics, proteomics, and metabolomics to enable life scientists with the necessary tools to perform this research to enhance current knowledge around disease mechanism and toxicity pathways. Additionally, Agilent’s collaboration with leading researchers in its Life Science Center in Bangalore, India are engaged into using this approach for systems biology, biomedical, and translational research.